title: Multiple T-cell responses to human immunodeficiency virus type 1 are enhanced by dendritic cells.
abstract: Human immunodeficiency virus type 1 (HIV-1)-specific T-cell reactivity has been related to protection from disease progression. Optimal T-cell reactivity to HIV-1 presumably requires antigen processing and presentation by professional antigen-presenting cells, particularly dendritic cells (DC). Here we examined whether multiple HIV-1-specific T-cell functions are enhanced by stimulation with HIV-1 peptide-loaded DC derived from HIV-1-infected subjects on antiretroviral therapy. We first found that mature DC increased the number of gamma interferon (IFN-gamma)-producing T cells detected by enzyme-linked immunospot assay to overlapping 15-mer peptides of HIV-1 Gag and Nef, compared to stimulation with peptide-loaded, immature DC or to peptides without DC. IFN-gamma production was lower in response to large pools of the Gag and Nef peptides, regardless of presentation by DC. We further observed that HIV-1 peptide-loaded, mature DC stimulated greater CD8(+) and CD4(+) T-cell proliferation than did the peptides without DC and that T-cell proliferation was lower in response to larger pools of the peptides. The lower T-cell IFN-gamma and proliferation responses to the larger peptide pools were related to lower T-cell viability. Finally, the number of polyfunctional CD8(+) and CD4(+) T cells stimulated by HIV-1 peptide-loaded, mature DC, defined as positive by intracellular staining for more than one immune mediator (IFN-gamma, interleukin 2, tumor necrosis factor alpha, macrophage inhibitory protein 1beta, or CD107a), was greater than that stimulated by the peptides alone. These results indicate that DC can enhance multiple types of HIV-1-specific T-cell functions.
authors.affiliation: Graduate School of Public Health and School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania 15261, USA.
authors.forename: Xiao-Li
authors.initials: XL
authors.lastname: Huang
authors.forename: Zheng
authors.initials: Z
authors.lastname: Fan
authors.forename: Luann
authors.initials: L
authors.lastname: Borowski
authors.forename: Charles R
authors.initials: CR
authors.lastname: Rinaldo
mesh_terms: D000595:Amino Acid Sequence; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D002454:Cell Differentiation; D003713:Dendritic Cells / Q000276:immunology* / Q000473:pathology; D015488:HIV Antigens / Q000235:genetics; D015658:HIV Infections / Q000276:immunology* / Q000473:pathology; D015497:HIV-1 / Q000235:genetics / Q000276:immunology*; D006801:Humans; D066298:In Vitro Techniques; D007371:Interferon-gamma / Q000096:biosynthesis; D008969:Molecular Sequence Data; D010446:Peptide Fragments / Q000235:genetics / Q000276:immunology; D013601:T-Lymphocytes / Q000276:immunology*; D054301:gag Gene Products, Human Immunodeficiency Virus / Q000235:genetics / Q000276:immunology; D054311:nef Gene Products, Human Immunodeficiency Virus / Q000235:genetics / Q000276:immunology
chemical_list: D015488:HIV Antigens; D010446:Peptide Fragments; D054301:gag Gene Products, Human Immunodeficiency Virus; D054311:nef Gene Products, Human Immunodeficiency Virus; C514837:nef protein, Human immunodeficiency virus 1; D007371:Interferon-gamma
references.citation: J Acquir Immune Defic Syndr. 2002 May 1;30(1):33-40
references.pmid: 12048361
references.citation: Immunity. 2007 Sep;27(3):406-16
references.pmid: 17892849
references.citation: J Acquir Immune Defic Syndr. 2007 May 1;45(1):20-7
references.pmid: 17310936
references.citation: AIDS. 2001 Sep 28;15(14):1749-56
references.pmid: 11579235
references.citation: J Virol Methods. 2007 Sep;144(1-2):115-21
references.pmid: 17543395
references.citation: J Immunol. 2004 May 1;172(9):5249-61
references.pmid: 15100263
references.citation: J Infect Dis. 2003 Jan 15;187(2):226-42
references.pmid: 12552447
references.citation: J Immunol. 2004 Nov 1;173(9):5372-80
references.pmid: 15494483
references.citation: Int Immunol. 2005 May;17(5):621-35
references.pmid: 15824067
references.citation: Nat Protoc. 2006;1(3):1507-16
references.pmid: 17406442
references.citation: Adv Pharmacol. 2008;56:75-92
references.pmid: 18086409
references.citation: Adv Immunol. 2007;95:111-48
references.pmid: 17869612
references.citation: J Immunol Methods. 2003 Dec;283(1-2):141-53
references.pmid: 14659906
references.citation: Cytometry. 2000 May 1;40(1):60-8
references.pmid: 10754518
references.citation: AIDS. 2006 Jan 9;20(2):171-80
references.pmid: 16511409
references.citation: J Intern Med. 2009 Jan;265(1):138-58
references.pmid: 19093966
references.citation: AIDS Res Hum Retroviruses. 2006 Mar;22(3):272-82
references.pmid: 16545014
references.citation: J Infect Dis. 2000 Apr;181(4):1249-63
references.pmid: 10762561
references.citation: Methods Mol Med. 2004;94:121-32
references.pmid: 14959826
references.citation: Vaccine. 2008 Jun 6;26(24):3002-7
references.pmid: 18180082
references.citation: AIDS Rev. 2004 Apr-Jun;6(2):79-88
references.pmid: 15332430
references.citation: Eur J Immunol. 2000 Jun;30(6):1676-82
references.pmid: 10898504
references.citation: Nat Rev Immunol. 2003 Aug;3(8):621-9
references.pmid: 12974477
references.citation: Trends Immunol. 2007 Nov;28(11):503-10
references.pmid: 17950666
references.citation: BMC Infect Dis. 2008 May 02;8:59
references.pmid: 18454861
references.citation: J Acquir Immune Defic Syndr. 2004 May 1;36(1):594-9
references.pmid: 15097302
references.citation: J Immunol Methods. 2003 Apr 1;275(1-2):19-29
references.pmid: 12667667
references.citation: Blood. 2009 Apr 23;113(17):3978-89
references.pmid: 19109229
references.citation: J Virol. 2005 Mar;79(5):3052-62
references.pmid: 15709025
references.citation: J Leukoc Biol. 2008 Jun;83(6):1530-40
references.pmid: 18364435
references.citation: AIDS Res Hum Retroviruses. 2002 Jun 10;18(9):611-8
references.pmid: 12079556
references.citation: Pediatr Res. 2007 Jun;61(6):692-7
references.pmid: 17426646
references.citation: Clin Vaccine Immunol. 2007 Sep;14(9):1127-37
references.pmid: 17634507
references.citation: Hum Immunol. 2004 May;65(5):523-36
references.pmid: 15172453
references.citation: J Virol. 2008 Apr;82(7):3391-404
references.pmid: 18199637
references.citation: J Immunol Methods. 2002 Feb 1;260(1-2):157-72
references.pmid: 11792386
references.citation: AIDS. 2004 Jul 23;18(11):1595-8
references.pmid: 15238779
references.citation: Front Biosci. 2007 Jan 01;12:2330-43
references.pmid: 17127243
references.citation: Nat Immunol. 2002 Nov;3(11):1061-8
references.pmid: 12368910
references.citation: Adv Immunol. 2002;80:1-70
references.pmid: 12078479
references.citation: J Virol. 2002 Jun;76(12):5925-36
references.pmid: 12021325
references.citation: J Immunol Methods. 2007 Sep 30;326(1-2):93-115
references.pmid: 17707394
references.citation: J Infect Dis. 2006 Dec 15;194(12):1650-60
references.pmid: 17109336
references.citation: Blood. 2006 Jun 15;107(12):4781-9
references.pmid: 16467198
references.citation: Annu Rev Immunol. 2000;18:767-811
references.pmid: 10837075
references.citation: PLoS One. 2007 Mar 28;2(3):e321
references.pmid: 17389912
references.citation: BMC Immunol. 2006 Apr 18;7:8
references.pmid: 16620386
references.citation: J Immunol. 1998 Nov 15;161(10):5284-95
references.pmid: 9820501
references.citation: Nat Med. 2008 Dec;14(12):1390-5
references.pmid: 18997777
references.citation: AIDS Res Hum Retroviruses. 2006 Nov;22(11):1081-90
references.pmid: 17147493
references.citation: J Exp Med. 2003 Dec 15;198(12):1909-22
references.pmid: 14676302
references.citation: J Immunol Methods. 2001 Sep 1;255(1-2):27-40
references.pmid: 11470284
references.citation: Int Immunol. 2006 Dec;18(12):1647-54
references.pmid: 17035346
references.citation: Clin Immunol. 2004 Mar;110(3):199-205
references.pmid: 15047198